Literature DB >> 27599296

A DOCK8-WIP-WASp complex links T cell receptors to the actin cytoskeleton.

Erin Janssen, Mira Tohme, Mona Hedayat, Marion Leick, Sudha Kumari, Narayanaswamy Ramesh, Michel J Massaad, Sumana Ullas, Veronica Azcutia, Christopher C Goodnow, Katrina L Randall, Qi Qiao, Hao Wu, Waleed Al-Herz, Dianne Cox, John Hartwig, Darrell J Irvine, Francis W Luscinskas, Raif S Geha.   

Abstract

Wiskott-Aldrich syndrome (WAS) is associated with mutations in the WAS protein (WASp), which plays a critical role in the initiation of T cell receptor-driven (TCR-driven) actin polymerization. The clinical phenotype of WAS includes susceptibility to infection, allergy, autoimmunity, and malignancy and overlaps with the symptoms of dedicator of cytokinesis 8 (DOCK8) deficiency, suggesting that the 2 syndromes share common pathogenic mechanisms. Here, we demonstrated that the WASp-interacting protein (WIP) bridges DOCK8 to WASp and actin in T cells. We determined that the guanine nucleotide exchange factor activity of DOCK8 is essential for the integrity of the subcortical actin cytoskeleton as well as for TCR-driven WASp activation, F-actin assembly, immune synapse formation, actin foci formation, mechanotransduction, T cell transendothelial migration, and homing to lymph nodes, all of which also depend on WASp. These results indicate that DOCK8 and WASp are in the same signaling pathway that links TCRs to the actin cytoskeleton in TCR-driven actin assembly. Further, they provide an explanation for similarities in the clinical phenotypes of WAS and DOCK8 deficiency.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27599296      PMCID: PMC5096816          DOI: 10.1172/JCI85774

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  62 in total

Review 1.  Signalling to actin: the Cdc42-N-WASP-Arp2/3 connection.

Authors:  M F Carlier; A Ducruix; D Pantaloni
Journal:  Chem Biol       Date:  1999-09

2.  Cellular localization of activated N-WASP using a conformation-sensitive antibody.

Authors:  P Sukumvanich; V DesMarais; C V Sarmiento; Y Wang; I Ichetovkin; G Mouneimne; S Almo; J Condeelis
Journal:  Cell Motil Cytoskeleton       Date:  2004-10

Review 3.  Wiskott-Aldrich syndrome protein--dynamic regulation of actin homeostasis: from activation through function and signal termination in T lymphocytes.

Authors:  Omri Matalon; Barak Reicher; Mira Barda-Saad
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

4.  WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha.

Authors:  Maria Dolores Gallego; Miguel A de la Fuente; Ines M Anton; Scott Snapper; Robert Fuhlbrigge; Raif S Geha
Journal:  Int Immunol       Date:  2005-09-01       Impact factor: 4.823

5.  Regulation of WASp by phosphorylation: Activation or other functions?

Authors:  Athanassios Dovas; Dianne Cox
Journal:  Commun Integr Biol       Date:  2010-03

6.  WIP is critical for T cell responsiveness to IL-2.

Authors:  Severine Le Bras; Michel Massaad; Suresh Koduru; Lalit Kumar; Michiko K Oyoshi; John Hartwig; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

7.  Differential roles for Wiskott-Aldrich syndrome protein in immune synapse formation and IL-2 production.

Authors:  Judy L Cannon; Janis K Burkhardt
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

8.  Cdc42 regulates Fc gamma receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich syndrome protein (WASP) and neural-WASP.

Authors:  Haein Park; Dianne Cox
Journal:  Mol Biol Cell       Date:  2009-09-09       Impact factor: 4.138

9.  Mechanism of N-WASP activation by CDC42 and phosphatidylinositol 4, 5-bisphosphate.

Authors:  R Rohatgi; H Y Ho; M W Kirschner
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

Review 10.  Recent advances in the biology of WASP and WIP.

Authors:  Narayanaswamy Ramesh; Raif Geha
Journal:  Immunol Res       Date:  2009       Impact factor: 4.505

View more
  50 in total

Review 1.  Negative Regulation of Type 2 Immunity.

Authors:  Dimitri A de Kouchkovsky; Sourav Ghosh; Carla V Rothlin
Journal:  Trends Immunol       Date:  2017-01-09       Impact factor: 16.687

2.  NKG2D-DAP10 signaling recruits EVL to the cytotoxic synapse to generate F-actin and promote NK cell cytotoxicity.

Authors:  Katelynn M Wilton; Brittany L Overlee; Daniel D Billadeau
Journal:  J Cell Sci       Date:  2019-07-18       Impact factor: 5.285

Review 3.  Origin, Organization, Dynamics, and Function of Actin and Actomyosin Networks at the T Cell Immunological Synapse.

Authors:  John A Hammer; Jia C Wang; Mezida Saeed; Antonio T Pedrosa
Journal:  Annu Rev Immunol       Date:  2018-12-21       Impact factor: 28.527

Review 4.  Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome.

Authors:  Helen C Su; Huie Jing; Pam Angelus; Alexandra F Freeman
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

5.  Host-microbial dialogues in atopic dermatitis.

Authors:  Tetsuro Kobayashi; Keisuke Nagao
Journal:  Int Immunol       Date:  2019-07-13       Impact factor: 4.823

Review 6.  Cytoskeletal control of B cell responses to antigens.

Authors:  Pavel Tolar
Journal:  Nat Rev Immunol       Date:  2017-07-10       Impact factor: 53.106

Review 7.  DOCK8 regulates signal transduction events to control immunity.

Authors:  Conor J Kearney; Katrina L Randall; Jane Oliaro
Journal:  Cell Mol Immunol       Date:  2017-04-03       Impact factor: 11.530

Review 8.  Human hyper-IgE syndrome: singular or plural?

Authors:  Qian Zhang; Bertrand Boisson; Vivien Béziat; Anne Puel; Jean-Laurent Casanova
Journal:  Mamm Genome       Date:  2018-08-09       Impact factor: 2.957

Review 9.  Crosstalk between WIP and Rho family GTPases.

Authors:  Inés M Antón; Carla Gómez-Oro; Sergio Rivas; Francisco Wandosell
Journal:  Small GTPases       Date:  2018-01-29

Review 10.  DOCK8 deficiency: Insights into pathophysiology, clinical features and management.

Authors:  Catherine M Biggs; Sevgi Keles; Talal A Chatila
Journal:  Clin Immunol       Date:  2017-06-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.